Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7484
Submission : 1988-05-10
Status :
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - INJECTABLE;INJECTION - 100 IU/ML **F...DOSAGE - INJECTABLE;INJECTION - 100 IU/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 17808
DOSAGE - INJECTABLE;INJECTION - 200 IU/ML
USFDA APPLICATION NUMBER - 17808
DOSAGE - SPRAY, METERED;NASAL - 200 IU/SPRAY ...DOSAGE - SPRAY, METERED;NASAL - 200 IU/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
USFDA APPLICATION NUMBER - 20313
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
27 Jan 2023
Reply
25 Mar 2022
Reply
29 Nov 2019
Reply
03 Aug 2019
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
23
PharmaCompass offers a list of Calcitonin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Calcitonin manufacturer or Calcitonin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Calcitonin manufacturer or Calcitonin supplier.
A Calcitonin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Calcitonin, including repackagers and relabelers. The FDA regulates Calcitonin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Calcitonin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Calcitonin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Calcitonin supplier is an individual or a company that provides Calcitonin active pharmaceutical ingredient (API) or Calcitonin finished formulations upon request. The Calcitonin suppliers may include Calcitonin API manufacturers, exporters, distributors and traders.
click here to find a list of Calcitonin suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Calcitonin DMF (Drug Master File) is a document detailing the whole manufacturing process of Calcitonin active pharmaceutical ingredient (API) in detail. Different forms of Calcitonin DMFs exist exist since differing nations have different regulations, such as Calcitonin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Calcitonin DMF submitted to regulatory agencies in the US is known as a USDMF. Calcitonin USDMF includes data on Calcitonin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Calcitonin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Calcitonin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Calcitonin Drug Master File in Japan (Calcitonin JDMF) empowers Calcitonin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Calcitonin JDMF during the approval evaluation for pharmaceutical products. At the time of Calcitonin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Calcitonin suppliers with JDMF on PharmaCompass.
A Calcitonin CEP of the European Pharmacopoeia monograph is often referred to as a Calcitonin Certificate of Suitability (COS). The purpose of a Calcitonin CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Calcitonin EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Calcitonin to their clients by showing that a Calcitonin CEP has been issued for it. The manufacturer submits a Calcitonin CEP (COS) as part of the market authorization procedure, and it takes on the role of a Calcitonin CEP holder for the record. Additionally, the data presented in the Calcitonin CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Calcitonin DMF.
A Calcitonin CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Calcitonin CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Calcitonin suppliers with CEP (COS) on PharmaCompass.
A Calcitonin written confirmation (Calcitonin WC) is an official document issued by a regulatory agency to a Calcitonin manufacturer, verifying that the manufacturing facility of a Calcitonin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Calcitonin APIs or Calcitonin finished pharmaceutical products to another nation, regulatory agencies frequently require a Calcitonin WC (written confirmation) as part of the regulatory process.
click here to find a list of Calcitonin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Calcitonin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Calcitonin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Calcitonin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Calcitonin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Calcitonin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Calcitonin suppliers with NDC on PharmaCompass.
Calcitonin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Calcitonin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Calcitonin GMP manufacturer or Calcitonin GMP API supplier for your needs.
A Calcitonin CoA (Certificate of Analysis) is a formal document that attests to Calcitonin's compliance with Calcitonin specifications and serves as a tool for batch-level quality control.
Calcitonin CoA mostly includes findings from lab analyses of a specific batch. For each Calcitonin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Calcitonin may be tested according to a variety of international standards, such as European Pharmacopoeia (Calcitonin EP), Calcitonin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Calcitonin USP).
Comment (3)
